Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Firefly Neuroscience (AIFF) over the last 15 years, with Q3 2025 value amounting to $7.0 million.

  • Firefly Neuroscience's Non-Current Assets rose 16368.1% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 million, marking a year-over-year increase of 16368.1%. This contributed to the annual value of $2.0 million for FY2024, which is 41113.99% up from last year.
  • As of Q3 2025, Firefly Neuroscience's Non-Current Assets stood at $7.0 million, which was up 16368.1% from $7.4 million recorded in Q2 2025.
  • In the past 5 years, Firefly Neuroscience's Non-Current Assets ranged from a high of $16.5 million in Q4 2021 and a low of $386000.0 during Q4 2023
  • Moreover, its 5-year median value for Non-Current Assets was $2.6 million (2024), whereas its average is $5.7 million.
  • Per our database at Business Quant, Firefly Neuroscience's Non-Current Assets surged by 488865.16% in 2021 and then plummeted by 9254.56% in 2023.
  • Quarter analysis of 5 years shows Firefly Neuroscience's Non-Current Assets stood at $16.5 million in 2021, then crashed by 68.6% to $5.2 million in 2022, then crashed by 92.55% to $386000.0 in 2023, then skyrocketed by 411.14% to $2.0 million in 2024, then soared by 253.62% to $7.0 million in 2025.
  • Its Non-Current Assets stands at $7.0 million for Q3 2025, versus $7.4 million for Q2 2025 and $2.0 million for Q1 2025.